ALLOGENE THERAPEUTICS INC (ALLO) Stock Balance Sheet
NASDAQ:ALLO - Nasdaq - US0197701065 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 42.45M | 75.22M | 83.16M | 61.90M | 173.30M | |||
| Marketable Securities | 237.59M | 217.26M | 365.54M | 455.40M | 284.00M | |||
| Receivables | 2.30M | 1.90M | 1.70M | 1.80M | 1.90M | |||
| Other Current Assets | 9.23M | 9.01M | 8.72M | 9.70M | 12.10M | |||
| Total Current Assets | 291.58M | 303.39M | 459.12M | 528.80M | 471.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 127.07M | 131.26M | 163.18M | 196.40M | 181.00M | |||
| Investments And Advances | 55.51M | 80.67M | 3.65M | 72.00M | 370.20M | |||
| Intangibles | N/A | N/A | N/A | N/A | N/A | |||
| Other Non-Current Assets | 33.83M | 33.39M | 16.90M | 19.90M | 16.10M | |||
| Total Non-Current Assets | 216.41M | 245.32M | 183.72M | 288.30M | 567.30M | |||
| TOTAL ASSETS | 507.98M | 548.71M | 642.84M | 817.10M | 1.04B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 24.96M | 30.13M | 31.10M | 39.70M | 37.50M | |||
| Accounts Payable | 5.06M | 5.39M | 5.90M | 13.90M | 10.30M | |||
| Other Current Liabilities | N/A | N/A | 86.00K | 900.00K | 400.00K | |||
| Total Current Liabilities | 30.02M | 35.52M | 37.08M | 54.50M | 48.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 92.57M | 91.01M | 93.53M | 96.70M | 74.10M | |||
| Total Non-Current Liabilities | 92.57M | 91.01M | 93.53M | 96.70M | 74.00M | |||
| TOTAL LIABILITIES | 122.59M | 126.53M | 130.60M | 151.20M | 122.20M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.88B | -1.82B | -1.56B | -1.24B | -903.30M | |||
| Additional Paid In Capital | 2.26B | 2.24B | 2.08B | 1.91B | 1.82B | |||
| Common Shares | 219.00K | 212.00K | 169.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 43.00K | -89.00K | -955.00K | -9.90M | -2.60M | |||
| Shares Outstanding | 218.60M | 212.21M | 168.64M | 144.40M | 142.60M | |||
| Tangible Book Value per Share | 1.76 | 1.99 | 3.04 | 4.61 | 6.43 | |||
| Total Shareholders' Equity | 385.39M | 422.18M | 512.23M | 665.90M | 916.40M | |||
| TOTAL LIABILITIES AND EQUITY | 507.98M | 548.71M | 642.84M | 817.10M | 1.04B | |||
| Statistics | ||||||||
| Current Ratio | 9.71 | 8.54 | 12.38 | 9.70 | 9.78 | |||
| Return On Assets (ROA) | -49.67% | -46.94% | -50.91% | -40.71% | -24.75% | |||
| Return On Equity (ROE) | -65.47% | -61.01% | -63.89% | -49.95% | -28.05% | |||
All data in USD , ROIC based on taxRate of 0.21